Previvo Genetics

San Jose, United States Founded: 2012 • Age: 14 yrs
Preimplantation genetic diagnostics and embryo screening devices are developed.
Annual revenue - Latest available
Total funding $6.8M 2 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Previvo Genetics

Previvo Genetics is a company based in San Jose (United States) founded in 2012 by John Buster. Previvo Genetics has raised $6.83 million across 2 funding rounds. Previvo Genetics operates in a competitive market with competitors including Gynesonics, Minerva Surgical, Channel Medsystems, NX Prenatal and LUMINELLE, among others.

  • Headquarter San Jose, United States
  • Founders John Buster
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Previvo Genetics, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $6.83 M (USD)

    in 2 rounds

  • Latest Funding Round
    $3.41 M (USD), Series A

    Sep 23, 2016

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Previvo Genetics

Previvo Genetics has successfully raised a total of $6.83M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.41 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Previvo Genetics

Investments
Premium access

Investment portfolio details for Previvo Genetics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Previvo Genetics

Premium access

Detailed financials for Previvo Genetics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Previvo Genetics Comparisons

Previvo Genetics Primary company
Description
Preimplantation genetic diagnostics and embryo screening dev...
Location
San Jose, United States
Founded Year
2012
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Previvo Genetics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Previvo Genetics

Previvo Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gynesonics, Minerva Surgical, Channel Medsystems, NX Prenatal and LUMINELLE, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
A minimally invasive ablation system for uterine fibroids is developed.
Locked Locked Locked
Minerva Surgical is focused on uterine health solutions.
Locked Locked Locked
Cryothermic technology for endometrial ablation to control heavy bleeding
Locked Locked Locked
Early warning blood tests for pregnancy complications are provided.
Locked Locked Locked
Hysteroscopy system is developed for minimally invasive endometrial procedures.
Locked Locked Locked
Diagnostic technologies for early disease detection are provided.
Premium access

Detailed competitors of Previvo Genetics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Previvo Genetics

Premium access

Complete news archive for Previvo Genetics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Previvo Genetics

Previvo Genetics was founded in 2012 and raised its 1st funding round 4 years after it was founded.

Previvo Genetics is headquartered in San Jose, United States. It is registered at San Jose, California, United States.

Previvo Genetics is a funded company, having raised a total of $6.83M across 2 funding rounds to date.

Founded in 2012 in San Jose, United States, Previvo Genetics operates in the biotechnology sector focused on reproductive health. The companys Previvo Uterine Lavage System is utilized to extract post-IVF blastocysts from the uterus noninvasively. These embryos are then screened for genetic abnormalities, with viable ones selected for re-implantation to support fertility treatments.

Previvo Genetics's top competitors include Gynesonics, NX Prenatal and Channel Medsystems.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available